Sex-Differences In Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (Supar) Levels And Its Impact On The Prognostic Significance Of Supar Among Patients With Coronary Artery Disease

Anurag Mehta,Chang Liu,Devinder Dhindsa,Yi-An Ko,Jeong Hwan Kim,Pratik Sandesara,Ayman Samman Tahhan,Matthew Topel,Heval Mohamed Kelli,Kasra Moazzami,Beka Bakhtadze,Ayman Alkhoder, Samir Martin,Laurence S. Sperling,Jochen Reiser,Salim Hayek,Arshed Quyyumi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2019）

Cited 0|Views76

No score

Abstract

Plasma soluble urokinase-type plasminogen activator receptor (suPAR) level is a strong predictor of adverse outcomes in patients with CAD. Women have higher suPAR levels, but the reason underlying this sex difference and its prognostic implication is unclear. We studied determinants of sex

Translated text

Key words

coronary artery disease,plasminogen,sex-differences sex-differences,urokinase-type

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined